Table 1 Clinical characteristics of participants

Age

51.5 ± 11.8

52.8 ± 8.7

56.1 ± 9.4

57.1 ± 9.7

Male gender, n (%)

15 (53.6)

33 (67.3)

17 (34)

64 (44.8)

BMI (kg/m²)

28.8 ± 5.2

26.1 ± 3.6

30 ± 5.6

29.7 ± 5.3

Ex-smokers, n (%)

5 (17.9)

6 (12.2)

11 (22)

5 (3.4)

 on Antihyper-tensive Treatment

NA

NA

39 (78)

90 (62.9)

 on insulin

7 (14.3)

45 (31.5)

 on oral hypoglycaemics

10 (28.6)

39 (27.3)

 On insulin plus oral hypoglycaemics

20 (40.8)

59 (41.3)

 On Statins

0

23 (46.9)

6 (12)

38 (26.6)

Duratn.T2D (yrs)

NA

7 ± 6

NA

11 ± 8^#

 SBP (mm Hg)

128 ± 15

125 ± 29

150 ± 29^*#

149 ± 34^*#

 DBP (mm Hg)

80 ± 7

83 ± 8

93 ± 12^*#

92 ± 10^*#

 PP (mm Hg)

48 ± 11

47 ± 9

57 ± 14^*#

63 ± 15^*#

 MBP (mm Hg)

96 ± 9

99 ± 9

112 ± 14^*#

112 ± 12^*#

 H Rate (bpm)

64 ± 10

74 ± 11

69 ± 11

78 ± 13

 CAVI^a

6.9 ± 1

7.4 ± 1.1^*

7.5 ± 1.1^*

8.3 ± 1.2^*§#

 haPWV (m/s) ^a

6.9 ± 0.8

7.2 ± 0.7^*

7.9 ± 1^*

8.5 ± 1^*§#

 SBP

124 ± 10

123 ± 20

144 ± 35*^#

152 ± 30*^#

 DBP

74 ± 9

75 ± 9

88 ± 13*^#

88 ± 13*^#

 PP

50 ± 6

51 ± 7

62 ± 12*^#

67 ± 14*^#

 MBP

90 ± 9

92 ± 8

108 ± 14*^#

110 ± 14*^#

 HR

65 ± 10

73 ± 16

66 ± 22

75 ± 16

 Aortic SBP

120 ± 12

116 ± 12

148 ± 27*^#

151 ± 26*^#

 Aortic PP

46 ± 7

39 ± 14

65 ± 17*^#

58 ± 25*^#

 Aortic AIx

29 ± 13

19 ± 11

38 ± 11*^#

30 ± 15*^#§

 Aortic PWV

7.8 ± 1.1

8.1 ± 0.9^*

8.7 ± 1.9*

9.1 ± 1.4^*#§